Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126411392 | 12641139 | 2 | F | 20160513 | 20160810 | 20160810 | 20160812 | EXP | PHHY2016CN104496 | NOVARTIS | 46.74 | YR | F | Y | 52.40000 | KG | 20160812 | MD | CN | CN |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126411392 | 12641139 | 1 | PS | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | Oral | 720 MG, BID | 17280 | MG | 50791 | 720 | MG | BID | |||||
126411392 | 12641139 | 2 | SS | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | Oral | 1080 MG, QD | 17280 | MG | 50791 | 1080 | MG | QD | |||||
126411392 | 12641139 | 3 | SS | MYFORTIC | MYCOPHENOLATE SODIUM | 1 | Oral | 360 MG, BID | 17280 | MG | 50791 | 360 | MG | BID | |||||
126411392 | 12641139 | 4 | SS | SIMULECT | BASILIXIMAB | 1 | Intravenous (not otherwise specified) | 20 MG, QD | 20 | MG | Y | 0 | 20 | MG | QD | ||||
126411392 | 12641139 | 5 | SS | SIMULECT | BASILIXIMAB | 1 | 20 | MG | Y | 0 | |||||||||
126411392 | 12641139 | 6 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Unknown | 520 MG, QD | 2020 | MG | Y | 0 | 520 | MG | INJECTION | QD | |||
126411392 | 12641139 | 7 | SS | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Unknown | 500 MG, QD | 2020 | MG | Y | 0 | 500 | MG | INJECTION | QD | |||
126411392 | 12641139 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | 80 MG, QD | 640 | MG | 0 | 80 | MG | TABLET | QD | ||||
126411392 | 12641139 | 9 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | 60 MG, QD | 640 | MG | 0 | 60 | MG | TABLET | QD | ||||
126411392 | 12641139 | 10 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | 40 MG, QD | 640 | MG | 0 | 40 | MG | TABLET | QD | ||||
126411392 | 12641139 | 11 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | 20 MG, QD | 640 | MG | 0 | 20 | MG | TABLET | QD | ||||
126411392 | 12641139 | 12 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | 15 MG, QD | 640 | MG | 0 | 15 | MG | TABLET | QD | ||||
126411392 | 12641139 | 13 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 2 MG, QD | 131 | MG | 0 | 2 | MG | CAPSULE | QD | ||||
126411392 | 12641139 | 14 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 3 MG, QD | 131 | MG | 0 | 3 | MG | CAPSULE | QD | ||||
126411392 | 12641139 | 15 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 6 MG, QD | 131 | MG | 0 | 6 | MG | CAPSULE | QD | ||||
126411392 | 12641139 | 16 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 5.5 MG, QD | 131 | MG | 0 | 5.5 | MG | CAPSULE | QD | ||||
126411392 | 12641139 | 17 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 4 MG, QD | 131 | MG | 0 | 4 | MG | CAPSULE | QD | ||||
126411392 | 12641139 | 18 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 3 MG, QD | 131 | MG | 0 | 3 | MG | CAPSULE | QD | ||||
126411392 | 12641139 | 19 | SS | TACROLIMUS. | TACROLIMUS | 1 | Unknown | 2 MG, QD | 131 | MG | 0 | 2 | MG | CAPSULE | QD | ||||
126411392 | 12641139 | 20 | C | AMBROXOL HYDROCHLORIDE | AMBROXOL HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 30 MG, BID | 1380 | MG | Y | 0 | 30 | MG | BID | ||||
126411392 | 12641139 | 21 | C | AMBROXOL HYDROCHLORIDE | AMBROXOL HYDROCHLORIDE | 1 | Respiratory (inhalation) | 30 MG, BID | 1380 | MG | Y | 0 | 30 | MG | BID | ||||
126411392 | 12641139 | 22 | C | AMOXICILLIN. | AMOXICILLIN | 1 | Intravenous (not otherwise specified) | 1.2 G, BID | 4.8000002 | G | Y | 0 | 1.2 | G | BID | ||||
126411392 | 12641139 | 23 | C | AMOXICILLIN. | AMOXICILLIN | 1 | Intravenous (not otherwise specified) | 1.2 G, BID | 4.8000002 | G | Y | 0 | 1.2 | G | BID | ||||
126411392 | 12641139 | 24 | C | CALCINATE//CALCIUM GLUCONATE | 2 | Intravenous (not otherwise specified) | 10 ML, QD | Y | 0 | 10 | ML | QD | |||||||
126411392 | 12641139 | 25 | C | CALCINATE//CALCIUM GLUCONATE | 2 | Intravenous (not otherwise specified) | 1 G, QD | Y | 0 | 1 | G | QD | |||||||
126411392 | 12641139 | 26 | C | CARBAZOCHROME SODIUM SULFONATE | CARBAZOCHROME SODIUM SULFONATE | 1 | Intravenous (not otherwise specified) | 80 MG, QD | 160 | MG | Y | 0 | 80 | MG | QD | ||||
126411392 | 12641139 | 27 | C | CARBAZOCHROME SODIUM SULFONATE | CARBAZOCHROME SODIUM SULFONATE | 1 | Intravenous (not otherwise specified) | 80 MG, QD | 160 | MG | Y | 0 | 80 | MG | QD | ||||
126411392 | 12641139 | 28 | C | CEFOPERAZONE SODIUM | CEFOPERAZONE SODIUM | 1 | Intravenous (not otherwise specified) | 2 G, Q12H | Y | 0 | 2 | G | INJECTION | Q12H | |||||
126411392 | 12641139 | 29 | C | CEFOPERAZONE SODIUM AND SULBACTAM SODIUM | CEFOPERAZONE SODIUMSULBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 2 G, Q12H | Y | 0 | 2 | G | INJECTION | Q12H | |||||
126411392 | 12641139 | 30 | C | DEXA CLINIT//DEXAMETHASONE | 2 | Intravenous (not otherwise specified) | 5 MG, QD | 10 | MG | Y | 0 | 5 | MG | QD | |||||
126411392 | 12641139 | 31 | C | DEXA CLINIT//DEXAMETHASONE | 2 | Intravenous (not otherwise specified) | 5 MG, QD | 10 | MG | Y | 0 | 5 | MG | QD | |||||
126411392 | 12641139 | 32 | C | DILTIAZEM HYDROCHLORIDE. | DILTIAZEM HYDROCHLORIDE | 1 | Oral | 30 MG, BID | 0 | 30 | MG | INJECTION | BID | ||||||
126411392 | 12641139 | 33 | C | DOPAMINE | DOPAMINEDOPAMINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 100 MG, UNK | Y | 0 | 100 | MG | INJECTION | ||||||
126411392 | 12641139 | 34 | C | ETAMSYLATE | ETHAMSYLATE | 1 | Intravenous (not otherwise specified) | 2 G, QD | Y | 0 | 2 | G | QD | ||||||
126411392 | 12641139 | 35 | C | FELODIPINE. | FELODIPINE | 1 | Oral | 5 MG, BID | 0 | 5 | MG | TABLET | BID | ||||||
126411392 | 12641139 | 36 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 100 MG, UNK | 200 | MG | Y | 0 | 100 | MG | |||||
126411392 | 12641139 | 37 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 20 MG, BID | 200 | MG | Y | 0 | 20 | MG | BID | ||||
126411392 | 12641139 | 38 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 20 MG, QD | 200 | MG | Y | 0 | 20 | MG | QD | ||||
126411392 | 12641139 | 39 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 20 MG, QD | 200 | MG | Y | 0 | 20 | MG | QD | ||||
126411392 | 12641139 | 40 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 40 MG, QD | 200 | MG | Y | 0 | 40 | MG | QD | ||||
126411392 | 12641139 | 41 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | 40 MG, QD | 200 | MG | Y | 0 | 40 | MG | QD | ||||
126411392 | 12641139 | 42 | C | GANCICLOVIR. | GANCICLOVIR | 1 | Intravenous (not otherwise specified) | 300 MG, BID | Y | 0 | 300 | MG | BID | ||||||
126411392 | 12641139 | 43 | C | HEPATITIS B IMMUNGLOBULIN HUMAN | 2 | Intramuscular | 100 IU, QD | 100 | IU | Y | 0 | 100 | IU | INJECTION | QD | ||||
126411392 | 12641139 | 44 | C | HUMAN IMMUNOGLOBULIN | HUMAN IMMUNOGLOBULIN G | 1 | Intravenous (not otherwise specified) | 10 G, QD | 10 | G | Y | 0 | 10 | G | INJECTION | QD | |||
126411392 | 12641139 | 45 | C | INSULIN | INSULIN NOS | 1 | Intravenous (not otherwise specified) | 6 IU, QD | Y | 0 | 6 | IU | QD | ||||||
126411392 | 12641139 | 46 | C | IRBESARTAN. | IRBESARTAN | 1 | Oral | 150 MG, BID | Y | 0 | 150 | MG | BID | ||||||
126411392 | 12641139 | 47 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, QD | 140 | MG | Y | 0 | 20 | MG | TABLET | QD | |||
126411392 | 12641139 | 48 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 20 MG, QD | 140 | MG | Y | 0 | 20 | MG | TABLET | QD | |||
126411392 | 12641139 | 49 | C | IRBESARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDEIRBESARTAN | 1 | Oral | 150 MG, QD | Y | 0 | 150 | MG | TABLET | QD | |||||
126411392 | 12641139 | 50 | C | IRON SUCROSE | IRON SUCROSE | 1 | Intravenous (not otherwise specified) | 100 MG, QD | Y | 0 | 100 | MG | INJECTION | QD | |||||
126411392 | 12641139 | 51 | C | LACTULOSE. | LACTULOSE | 1 | Oral | 15 ML, QD | Y | 0 | 15 | ML | QD | ||||||
126411392 | 12641139 | 52 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 30 MG, BID | 0 | 30 | MG | CAPSULE | BID | ||||||
126411392 | 12641139 | 53 | C | LEVOFLOXACIN LACTATE | LEVOFLOXACIN | 1 | Intravenous (not otherwise specified) | 0.5 G, QD | Y | 0 | .5 | G | TABLET | QD | |||||
126411392 | 12641139 | 54 | C | MANNITOL. | MANNITOL | 1 | Intravenous (not otherwise specified) | 125 ML, QD | 125 | ML | Y | 0 | 125 | ML | QD | ||||
126411392 | 12641139 | 55 | C | OMEPRAZOLE SODIUM | OMEPRAZOLE SODIUM | 1 | Intravenous (not otherwise specified) | 40 MG, BID | 160 | MG | Y | 0 | 40 | MG | INJECTION | BID | |||
126411392 | 12641139 | 56 | C | ORNIDAZOLE | ORNIDAZOLE | 1 | Intravenous (not otherwise specified) | 250 MG, QD | Y | 0 | 250 | MG | INJECTION | QD | |||||
126411392 | 12641139 | 57 | C | PARACETAMOL W/TRAMADOL HYDROCHLORIDE | ACETAMINOPHENTRAMADOL HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 1 CAP, QD | Y | 0 | QD | ||||||||
126411392 | 12641139 | 58 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 3 G, QD | 6 | G | Y | 0 | 3 | G | TABLET | QD | |||
126411392 | 12641139 | 59 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 3 G, QD | 6 | G | Y | 0 | 3 | G | TABLET | QD | |||
126411392 | 12641139 | 60 | C | PHENA//PROMETHAZINE HYDROCHLORIDE | 2 | Intramuscular | 50 MG, QD | Y | 0 | 50 | MG | INJECTION | QD | ||||||
126411392 | 12641139 | 61 | C | PROTAMINE SULFATE. | PROTAMINE SULFATE | 1 | Intravenous (not otherwise specified) | 50 MG, QD | 100 | MG | Y | 0 | 50 | MG | INJECTION | QD | |||
126411392 | 12641139 | 62 | C | RECOMBINANT HUMAN ERYTHROPOIETIN | ERYTHROPOIETIN | 1 | Intravenous (not otherwise specified) | 10000 IU, QOD | Y | 0 | 10000 | IU | INJECTION | ||||||
126411392 | 12641139 | 63 | C | GLUTATHIONE | GLUTATHIONE | 1 | Intravenous (not otherwise specified) | 1.8 G, QD | Y | 0 | 1.8 | G | INJECTION | QD | |||||
126411392 | 12641139 | 64 | C | SODIUM BICARBONATE. | SODIUM BICARBONATE | 1 | Oral | 1 G, TID | 0 | 1 | G | TABLET | TID | ||||||
126411392 | 12641139 | 65 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 20 MG, QD | Y | 0 | 20 | MG | TABLET | QD | |||||
126411392 | 12641139 | 66 | C | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Y | 0 | TABLET | ||||||||||
126411392 | 12641139 | 67 | C | SULFUR HEXAFLUORIDE | SULFUR HEXAFLUORIDE | 1 | Intravenous (not otherwise specified) | 59 MG, QD | Y | 0 | 59 | MG | INJECTION | QD | |||||
126411392 | 12641139 | 68 | C | TAMSULOSIN HYDROCHLORIDE. | TAMSULOSIN HYDROCHLORIDE | 1 | Oral | 0.2 MG, QN | 0 | .2 | MG | CAPSULE | |||||||
126411392 | 12641139 | 69 | C | VITAMIN B6 | PYRIDOXINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 0.2 G, QD | Y | 0 | .2 | G | QD | ||||||
126411392 | 12641139 | 70 | C | G-VITAMIN C | 2 | Intravenous (not otherwise specified) | 2 G, QD | Y | 0 | 2 | G | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126411392 | 12641139 | 1 | Prophylaxis against transplant rejection |
126411392 | 12641139 | 2 | Immunosuppressant drug therapy |
126411392 | 12641139 | 4 | Prophylaxis against transplant rejection |
126411392 | 12641139 | 5 | Immunosuppressant drug therapy |
126411392 | 12641139 | 6 | Product used for unknown indication |
126411392 | 12641139 | 8 | Prophylaxis against transplant rejection |
126411392 | 12641139 | 9 | Immunosuppressant drug therapy |
126411392 | 12641139 | 13 | Prophylaxis against transplant rejection |
126411392 | 12641139 | 14 | Immunosuppressant drug therapy |
126411392 | 12641139 | 20 | Sputum abnormal |
126411392 | 12641139 | 22 | Inflammation |
126411392 | 12641139 | 24 | Mineral supplementation |
126411392 | 12641139 | 25 | Hypersensitivity |
126411392 | 12641139 | 26 | Inflammation |
126411392 | 12641139 | 28 | Inflammation |
126411392 | 12641139 | 29 | Inflammation |
126411392 | 12641139 | 30 | Hypersensitivity |
126411392 | 12641139 | 32 | Hypertension |
126411392 | 12641139 | 33 | Capillary disorder |
126411392 | 12641139 | 34 | Haemostasis |
126411392 | 12641139 | 35 | Hypertension |
126411392 | 12641139 | 36 | Diuretic therapy |
126411392 | 12641139 | 42 | Prophylaxis |
126411392 | 12641139 | 43 | Prophylaxis |
126411392 | 12641139 | 44 | Nutritional supplementation |
126411392 | 12641139 | 45 | Product used for unknown indication |
126411392 | 12641139 | 46 | Hypertension |
126411392 | 12641139 | 47 | Diuretic therapy |
126411392 | 12641139 | 49 | Hypertension |
126411392 | 12641139 | 50 | Product used for unknown indication |
126411392 | 12641139 | 51 | Constipation |
126411392 | 12641139 | 52 | Prophylaxis |
126411392 | 12641139 | 53 | Inflammation |
126411392 | 12641139 | 54 | Oedema |
126411392 | 12641139 | 55 | Prophylaxis |
126411392 | 12641139 | 56 | Inflammation |
126411392 | 12641139 | 57 | Analgesic therapy |
126411392 | 12641139 | 58 | Mineral supplementation |
126411392 | 12641139 | 60 | Hypersensitivity |
126411392 | 12641139 | 61 | Haemostasis |
126411392 | 12641139 | 62 | Platelet disorder |
126411392 | 12641139 | 63 | Prophylaxis |
126411392 | 12641139 | 64 | Hyperchlorhydria |
126411392 | 12641139 | 65 | Swelling |
126411392 | 12641139 | 66 | Diuretic therapy |
126411392 | 12641139 | 67 | Product used for unknown indication |
126411392 | 12641139 | 68 | Diuretic therapy |
126411392 | 12641139 | 69 | Nutritional supplementation |
126411392 | 12641139 | 70 | Nutritional supplementation |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126411392 | 12641139 | HO |
126411392 | 12641139 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126411392 | 12641139 | Blood glucose increased | |
126411392 | 12641139 | Blood urea increased | |
126411392 | 12641139 | Haemoglobin decreased | |
126411392 | 12641139 | Incision site pain | |
126411392 | 12641139 | Lymphocyte count decreased | |
126411392 | 12641139 | Pyrexia | |
126411392 | 12641139 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126411392 | 12641139 | 1 | 20160512 | 20160520 | 0 | |
126411392 | 12641139 | 2 | 20160520 | 20160523 | 0 | |
126411392 | 12641139 | 3 | 20160523 | 0 | ||
126411392 | 12641139 | 4 | 20160512 | 20160512 | 0 | |
126411392 | 12641139 | 6 | 20160512 | 20160512 | 0 | |
126411392 | 12641139 | 7 | 20160513 | 20160515 | 0 | |
126411392 | 12641139 | 8 | 20160515 | 20160516 | 0 | |
126411392 | 12641139 | 9 | 20160516 | 20160517 | 0 | |
126411392 | 12641139 | 10 | 20160517 | 20160518 | 0 | |
126411392 | 12641139 | 11 | 20160518 | 20160531 | 0 | |
126411392 | 12641139 | 12 | 20160531 | 0 | ||
126411392 | 12641139 | 13 | 20160515 | 20160520 | 0 | |
126411392 | 12641139 | 14 | 20160520 | 20160523 | 0 | |
126411392 | 12641139 | 15 | 20160523 | 20160527 | 0 | |
126411392 | 12641139 | 16 | 20160527 | 20160607 | 0 | |
126411392 | 12641139 | 17 | 20160607 | 20160608 | 0 | |
126411392 | 12641139 | 18 | 20160609 | 20160609 | 0 | |
126411392 | 12641139 | 19 | 20160610 | 0 | ||
126411392 | 12641139 | 20 | 20160513 | 20160518 | 0 | |
126411392 | 12641139 | 21 | 20160513 | 20160529 | 0 | |
126411392 | 12641139 | 22 | 20160512 | 20160520 | 0 | |
126411392 | 12641139 | 23 | 20160609 | 20160610 | 0 | |
126411392 | 12641139 | 24 | 20160513 | 20160514 | 0 | |
126411392 | 12641139 | 25 | 20160527 | 20160527 | 0 | |
126411392 | 12641139 | 26 | 20160513 | 20160513 | 0 | |
126411392 | 12641139 | 27 | 20160515 | 20160515 | 0 | |
126411392 | 12641139 | 28 | 20160525 | 20160602 | 0 | |
126411392 | 12641139 | 29 | 20160610 | 20160623 | 0 | |
126411392 | 12641139 | 30 | 20160514 | 20160514 | 0 | |
126411392 | 12641139 | 31 | 20160609 | 20160609 | 0 | |
126411392 | 12641139 | 32 | 20160516 | 0 | ||
126411392 | 12641139 | 33 | 20160513 | 20160515 | 0 | |
126411392 | 12641139 | 34 | 20160513 | 20160513 | 0 | |
126411392 | 12641139 | 35 | 20160514 | 0 | ||
126411392 | 12641139 | 36 | 20160513 | 20160518 | 0 | |
126411392 | 12641139 | 37 | 20160519 | 20160519 | 0 | |
126411392 | 12641139 | 38 | 20160520 | 20160520 | 0 | |
126411392 | 12641139 | 39 | 20160522 | 20160522 | 0 | |
126411392 | 12641139 | 40 | 20160525 | 20160526 | 0 | |
126411392 | 12641139 | 41 | 20160528 | 20160528 | 0 | |
126411392 | 12641139 | 42 | 20160605 | 20160619 | 0 | |
126411392 | 12641139 | 43 | 20160512 | 20160512 | 0 | |
126411392 | 12641139 | 44 | 20160512 | 20160512 | 0 | |
126411392 | 12641139 | 45 | 20160515 | 20160515 | 0 | |
126411392 | 12641139 | 46 | 20160617 | 20160622 | 0 | |
126411392 | 12641139 | 47 | 20160524 | 20160524 | 0 | |
126411392 | 12641139 | 48 | 20160603 | 20160608 | 0 | |
126411392 | 12641139 | 49 | 20160523 | 20160617 | 0 | |
126411392 | 12641139 | 50 | 20160522 | 20160527 | 0 | |
126411392 | 12641139 | 51 | 20160520 | 20160520 | 0 | |
126411392 | 12641139 | 52 | 20160520 | 0 | ||
126411392 | 12641139 | 53 | 20160524 | 20160530 | 0 | |
126411392 | 12641139 | 54 | 20160512 | 20160512 | 0 | |
126411392 | 12641139 | 55 | 20160512 | 20160520 | 0 | |
126411392 | 12641139 | 56 | 20160610 | 20160610 | 0 | |
126411392 | 12641139 | 57 | 20160513 | 20160513 | 0 | |
126411392 | 12641139 | 58 | 20160515 | 20160515 | 0 | |
126411392 | 12641139 | 59 | 20160523 | 20160523 | 0 | |
126411392 | 12641139 | 60 | 20160513 | 20160514 | 0 | |
126411392 | 12641139 | 61 | 20160512 | 20160513 | 0 | |
126411392 | 12641139 | 62 | 20160522 | 20160608 | 0 | |
126411392 | 12641139 | 63 | 20160513 | 20160621 | 0 | |
126411392 | 12641139 | 64 | 20160619 | 0 | ||
126411392 | 12641139 | 65 | 20160531 | 20160608 | 0 | |
126411392 | 12641139 | 67 | 20160620 | 20160620 | 0 | |
126411392 | 12641139 | 68 | 20160613 | 0 | ||
126411392 | 12641139 | 69 | 20160513 | 20160518 | 0 | |
126411392 | 12641139 | 70 | 20160513 | 20160518 | 0 |